Aventis and the Nobel Foundation form collaboration to support Nobel e-Museum

05-Feb-2001

Aventis and the Nobel Foundation announced today a new collaboration to expand the Internet-based Nobel e-Museum (NeM) (www.nobel.se and www.nobelprize.org) as part of the centennial celebration of the Nobel Prize. Aventis, through its Aventis Pharma prescription drugs and Aventis Pasteur vaccines subsidiaries, will sponsor the medical part of a new NeM section called "Science & Technology" that will offer educational multimedia as well as text documents about medical and biological discoveries rewarded with Nobel Prizes during the last century. A central theme for the collaboration will be to highlight the relationship between basic research and practical applications in medicine. The NeM is operated by the Nobel Foundation Museum Association, which is an organization initiated by the Nobel Foundation to organize its museum projects and exhibitions. Aventis has agreed to support the Nobel e-Museum as part of a three-year agreement, which can be extended for an additional two years. Content in the new "Science & Technology" section is scheduled to begin appearing during the second half of 2001 and in time for the Nobel Jubilee in December 2001. The Nobel e-Museum will have full editorial control and responsibility for the site's content. "Our collaboration with Aventis provides the Nobel Foundation with an opportunity to further develop its virtual Nobel museum. With the support of Aventis, the Nobel e-Museum will be able to illustrate how discoveries in basic sciences have resulted in new diagnostic and therapeutic applications," said Michael Sohlman, Executive Director of the Nobel Foundation. The Nobel e-Museum (NeM) is a virtual museum of science and culture on Internet that can be visited at www.nobel.se and www.nobelprize.org from anywhere in the world. It is open all the time and has almost unlimited virtual space. It presents information about all Nobel Prizes in physics, chemistry, medicine, literature and peace since 1901. The information consists of more than 7,000 text pages, about 3,000 pictures, databases, search engines as well as audio and video documents. It also functions as the official web site of the Nobel Foundation. Major events such as the Nobel Lectures and the Nobel Prize award ceremony are broadcast on the Internet site. In 2000, some 2.3 million visitors around the world opened more than 107 million documents on the site; most visitors come from the United States, Western Europe and some parts of Asia. The educational multimedia content for the site developed through the Nobel-Aventis collaboration will be available free of charge to Internet users around the world. "Both the Nobel Foundation and Aventis share a strong common interest in promoting the public understanding of science and culture," said Thierry Soursac, Executive Vice President, Head of Global Commercial Operations at Aventis Pharma. "This project is also a wonderful opportunity to help support the learning experience of young scholars, particularly in view of the exciting multimedia learning experience offered by the Nobel e-Museum," said Jean-Jacques Bertrand, Chairman and CEO of Aventis Pasteur and Deputy to the CEO of Aventis Pharma. "We want to help further the scientific education of students worldwide through the Internet, some of whom may even end up one day winning a Nobel Prize." The project is of particular interest to Aventis since the first Nobel Prize in physiology or medicine was awarded in 1901 to Emil von Behring, founder of the first plasma protein company that is still a part of the Aventis organization through the subsidiary Aventis Behring. The more than 170 Nobel Prizes in Physiology or Medicine awarded since then are indeed landmarks in the history of medical research.

https://www.chemeurope.com/en/news/1154/aventis-and-the-nobel-foundation-form-collaboration-to-support-nobel-e-museum.html